IMMUNE SYSTEM DISEASES
Clinical trials for IMMUNE SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new IMMUNE SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for IMMUNE SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CRISPR's diabetes cell therapy trial ends early
Disease control TerminatedThis early-stage study tested a new cell therapy called VCTX211 in 5 people with long-standing type 1 diabetes. The goal was to see if the implanted cells could safely help the body produce its own insulin again. The trial was stopped early, and results are not yet available.
Matched conditions: IMMUNE SYSTEM DISEASES
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 26, 2026 09:50 UTC
-
New hope for arthritis sufferers? drug trial targets joint pain
Disease control TerminatedThis study tested a drug called peresolimab in adults with moderate to severe rheumatoid arthritis, a condition causing joint pain and swelling. The goal was to see if the drug safely improves symptoms like tender and swollen joints. The trial was stopped early, but results may s…
Matched conditions: IMMUNE SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 22, 2026 13:53 UTC